CompanyNews

Revolutionizing Adult Epilepsy Treatment: Our Expanded Research Using Super SNEDDS Technology

In the evolving landscape of neurological disorders, epilepsy stands out as a complex challenge that affects millions of adults worldwide. The quest for more effective treatments has led us to innovate and explore groundbreaking methodologies in drug delivery systems. At the forefront of our research is the expanded application of our advanced Super Self-Nanoemulsifying Drug Delivery System (Super SNEDDS) technology.

Read More »

EmpowerPharm Inc. is delighted to announce the outcome of their Phase 2 clinical trial assessing Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD)

EmpowerPharm Inc. https://empowerpharm.ca/ is delighted to announce the outcome of their Phase 2 clinical trial assessing the dose finding, efficacy, safety, and tolerability of Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD). The results demonstrated efficacy for a subset of patients suffering from moderate to severe SAD.

Read More »